Tobacco Control Laws in India: Ambit of restrictions on consumption, advertisements and packaging of cigarettes

Introduction

The consumption of tobacco products continues to be a major public health issue in India, with smoking-related diseases causing numerous deaths annually. According to estimates cited in the World Health Organization’s (“WHO”) ‘Economic Costs of Diseases and Deaths Attributable to Tobacco Use in India’ study, “the economic burden of diseases and premature deaths attributable to smoking and smokeless tobacco use by persons over 35 years of age in India is over 1% of India’s GDP”. Further, the expenditure incurred to treat tobacco related illnesses and diseases accounts for 5.3% of the total private and public health spending in India in a year[1]. Continue Reading Tobacco Control Laws in India: Ambit of restrictions on consumption, advertisements and packaging of cigarettes

Oxytocin Ban in India

Oxytocin is life-saving drug that is used for the induction and assistance of labour in women during childbirth. It is also used to stop postpartum haemorrhage (excessive bleeding). The drug also aids milk secretion during the lactation process. Because of its inherent lifesaving properties in humans and cattle, Oxytocin is identified as an essential medicine in the 20th World Health Organization (WHO) Model List of Essential Medicines, March, 2017[i]. It also continues to be included as an essential medicine in the National List of Essential Medicines (NLEM), 2015[ii].
Continue Reading The Oxytocin Ban Story